Xiaona Huang Selected Research

Xiaona Huang Research Topics

Disease

21	Neoplasms (Cancer) 05/2024 - 12/2013
5	Bites and Stings (Sting) 12/2022 - 11/2014
4	Neoplasm Metastasis (Metastasis) 03/2024 - 02/2015
4	Retinal Degeneration 11/2023 - 01/2022
3	Gliosis 02/2024 - 01/2023
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 02/2024 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 04/2023 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 11/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2016
2	Breast Neoplasms (Breast Cancer) 12/2020 - 02/2015
2	Lung Neoplasms (Lung Cancer) 10/2019 - 01/2018
1	Corneal Injuries 11/2023
1	Nausea 04/2023
1	Vomiting 04/2023
1	Glioma (Gliomas) 12/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Pathologic Processes 01/2022
1	Ganglion Cysts (Ganglion) 01/2022
1	Postpartum Depression (Post-Natal Depression) 01/2021
1	Newborn Respiratory Distress Syndrome 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	COVID-19 11/2020
1	Wounds and Injuries (Trauma) 11/2020
1	Severe Acute Respiratory Syndrome 11/2020
1	Shock 06/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Neonatal Sepsis 01/2020
1	Rupture 01/2020
1	Carcinoma (Carcinomatosis) 10/2019
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Cicatrix (Scar) 01/2018
1	Malnutrition (Nutritional Deficiencies) 11/2017
1	Growth Disorders 11/2017
1	Intellectual Disability (Idiocy) 07/2015

Drug/Important Bio-Agent (IBA)

5	Retinaldehyde (Retinal)IBA 02/2024 - 01/2022
4	InterferonsIBA 12/2022 - 05/2016
3	RNA (Ribonucleic Acid)IBA 10/2023 - 10/2019
3	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2013
3	Interferon Type IIBA 11/2017 - 11/2014
2	AntibodiesIBA 05/2024 - 11/2020
2	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2022
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 01/2014
2	Indicators and Reagents (Reagents)IBA 01/2021 - 11/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2014
2	LuciferasesIBA 11/2016 - 06/2015
2	tdTomatoIBA 11/2016 - 06/2015
1	Chemokine CXCL10IBA 03/2024
1	sodium iodateIBA 02/2024
1	Activins (Activin)IBA 12/2023
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2023
1	AntioxidantsIBA 11/2023
1	Glutathione (Reduced Glutathione)IBA 11/2023
1	Free Radical ScavengersIBA 11/2023
1	N-methyladenosineIBA 10/2023
1	EnzymesIBA 04/2023
1	Macrophage Colony-Stimulating FactorIBA 01/2023
1	pexidartinibIBA 01/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2023
1	Adenosine Monophosphate (AMP)IBA 12/2022
1	ZincIBA 12/2022
1	cyclic diadenosine phosphateIBA 12/2022
1	PolymersIBA 12/2022
1	NivolumabIBA 10/2022
1	Combined VaccinesIBA 10/2022
1	Cancer VaccinesIBA 10/2022
1	VaccinesIBA 10/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Nerve Growth Factors (Neurotrophins)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	B7-H1 AntigenIBA 01/2021
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2021
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Tobacco Smoke Pollution (Passive Smoking)IBA 11/2020
1	Immunoglobulin M (IgM)IBA 11/2020
1	Immunoglobulin G (IgG)IBA 11/2020
1	Drinking WaterIBA 11/2020
1	Explosive Agents (Explosives)IBA 06/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Long Noncoding RNAIBA 10/2019
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2019
1	Therapeutic UsesIBA 01/2018
1	fedratinibIBA 01/2018
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2014
1	Proteins (Proteins, Gene)FDA Link 11/2014

Therapy/Procedure

10	Radiotherapy 03/2024 - 11/2014
8	Therapeutics 05/2024 - 02/2015
3	Drug Therapy (Chemotherapy) 04/2023 - 05/2016
3	Immunotherapy 10/2022 - 01/2021
1	Intraperitoneal Injections 02/2024
1	Cell Transplantation 01/2022
1	Neoadjuvant Therapy 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Radioimmunotherapy 01/2021
1	Umbilical Cord Clamping 01/2020
1	Kangaroo-Mother Care Method 01/2020
1	Cesarean Section (Caesarean Section) 01/2018
1	Splenectomy 11/2016
1	Percutaneous Collagen Induction 07/2015